New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy
Hematopoietic stem cell transplantation (HSCT)-associated thrombotic microangiopathy (TA-
TMA) is an understudied complication of HSCT that significantly affects transplant-related …
TMA) is an understudied complication of HSCT that significantly affects transplant-related …
Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation
BS Cho, SA Yahng, SE Lee, KS Eom, YJ Kim… - …, 2010 - journals.lww.com
Background. The lack of an accepted definition of transplantation-associated thrombotic
microangiopathy (TMA) has led the Blood and Marrow Transplants Clinical Trials Network …
microangiopathy (TMA) has led the Blood and Marrow Transplants Clinical Trials Network …
Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort
M Schoettler, LE Lehmann, S Margossian… - Blood …, 2020 - ashpublications.org
Transplant-associated thrombotic microangiopathy (TA-TMA) is a well-recognized
complication of hematopoietic cell transplantation (HCT). Diagnosis is challenging and in …
complication of hematopoietic cell transplantation (HCT). Diagnosis is challenging and in …
Transplantation-associated thrombotic microangiopathy risk stratification: is there a window of opportunity to improve outcomes?
Transplantation-associated thrombotic microangiopathy (TA-TMA) can range from a self-
limiting condition to a lethal transplantation complication. It is important to identify TA-TMA …
limiting condition to a lethal transplantation complication. It is important to identify TA-TMA …
[HTML][HTML] Distribution of transplantation-associated thrombotic microangiopathy (TA-TMA) and comparison between renal TA-TMA and intestinal TA-TMA: autopsy study
R Yamada, T Nemoto, K Ohashi, A Tonooka… - Biology of Blood and …, 2020 - Elsevier
Transplantation-associated thrombotic microangiopathy (TA-TMA) is an important
complication of hematopoietic stem cell transplantation. To date, information regarding the …
complication of hematopoietic stem cell transplantation. To date, information regarding the …
[HTML][HTML] Transplant-associated thrombotic microangiopathy is a multifactorial disease unresponsive to immunosuppressant withdrawal
Transplant-associated thrombotic microangiopathy (TA-TMA) after allogeneic hematopoietic
cell transplantation (HCT) has not been well characterized in large population studies with …
cell transplantation (HCT) has not been well characterized in large population studies with …
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant
Transplant-associated thrombotic microangiopathy (TA-TMA) is a severe complication of
hematopoietic stem cell transplantation (HSCT). A single-center prospective screening study …
hematopoietic stem cell transplantation (HSCT). A single-center prospective screening study …
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults
Transplant-associated thrombotic microangiopathy (TMA) leads to generalized endothelial
dysfunction that can progress to multiorgan injury, and severe cases are associated with …
dysfunction that can progress to multiorgan injury, and severe cases are associated with …
Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management
CC Dvorak, C Higham, KA Shimano - Frontiers in Pediatrics, 2019 - frontiersin.org
Transplant-associated thrombotic microangiopathy (TA-TMA) is an endothelial damage
syndrome that is increasingly identified as a complication of both autologous and allogeneic …
syndrome that is increasingly identified as a complication of both autologous and allogeneic …
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy
M Schoettler, S Chonat, K Williams… - Current opinion in …, 2021 - journals.lww.com
Novel therapeutic agents for TA-TMA inhibition of the complement system are under
investigation and prophylactic strategies of endothelial protection are emerging. Further …
investigation and prophylactic strategies of endothelial protection are emerging. Further …